מתוך medicontext.co.il
WESTPORT, CT (Reuters Health) – At 2 weeks of age, premature infants have high plasma vitamin K levels because of supplementation, according to a report in the November issue of Pediatrics. The authors suggest that "consideration should be given to reducing the amount of parenteral vitamin K supplementation in the first few weeks of life in premature infants."
Dr. Deepak Kumar, of MetroHealth Medical Canter, Cleveland, Ohio, and colleagues measured plasma vitamin K and plasma protein-induced in vitamin K absence (PIVKA II) from birth until 40 weeks' postconceptional age in 44 premature infants. They were divided into three groups: group 1, 28 weeks' gestation or less; group 2, 29 to 32 weeks; group 3, 33 to 36 weeks.
The team notes that 1-mg intramuscular vitamin K was administered at birth, followed by 60 µg/day for infants less than 1000 g or 130 µg/day for those 1000 g or more via total parenteral nutrition. "After hyperalimentation, most received vitamin K-fortified enteral feedings with the remainder receiving unfortified breast milk."
Ten infants in each group completed the study. At 2 weeks of age, vitamin K plasma levels were highest in group 1 at 130.7 ng/mL versus 27.2 ng/mL in group 3, the researchers found. By 40 weeks' postconception, plasma levels of vitamin K were similar in all groups, ranging from 5.4 ng/mL to: 9.3 ng/mL.
"None of the postnatal plasma samples had any detectable PIVKA II," the investigators report, confirming adequate vitamin K status.
"Optimal vitamin K requirements of premature infants are undefined, but present evidence suggests that parenteral vitamin K supplementation in the first few weeks of life should be reduced," Dr. Kumar and colleagues conclude.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!